The examine evaluated the once-daily utility of Zoryve cream 0.05% for 4 weeks in 101 infants with gentle to average AD. Credit score: Luca Lorenzelli/Shutterstock.com. Arcutis has reported constructive topline information from the INTEGUMENT-INFANT Section II trial evaluating Zoryve (roflumilast) cream 0.05% in infants aged three months to lower than 24 months with gentle to average atopic dermatitis (AD). Zoryve […]